Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings
Boadie W. Dunlop, Jaclyn Gray, Mark Hyman Rapaport
Behavioral Sciences (2017) Vol. 7, Iss. 3, pp. 40-40
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
Eugenio Mercuri, Nicolas Deconinck, Elena Mazzone, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 42-52
Closed Access | Times Cited: 150
Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial
Jeanette M. Johnstone, Irene Hatsu, Gabriella Tost, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2021) Vol. 61, Iss. 5, pp. 647-661
Open Access | Times Cited: 44
Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19–Related Olfactory Dysfunction
Shruti Gupta, Jake J. Lee, Amber Perrin, et al.
JAMA Otolaryngology–Head & Neck Surgery (2022) Vol. 148, Iss. 9, pp. 830-830
Open Access | Times Cited: 27
Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss
Amish M. Khan, Jeffrey Piccirillo, Dorina Kallogjeri, et al.
JAMA Otolaryngology–Head & Neck Surgery (2022) Vol. 149, Iss. 2, pp. 141-141
Open Access | Times Cited: 23
Using New and Innovative Technologies to Assess Clinical Stage in Early Intervention Youth Mental Health Services: Evaluation Study
Laura Ospina‐Pinillos, Tracey A Davenport, Frank Iorfino, et al.
Journal of Medical Internet Research (2018) Vol. 20, Iss. 9, pp. e259-e259
Open Access | Times Cited: 41
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
Taylor Fields, Marc C. Patterson, Tatiana Brémovà-Ertl, et al.
Trials (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
Wenjin Chen, Mengzhuang Gou, Leilei Wang, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 18-29
Closed Access | Times Cited: 13
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
Marta Ielmini, Nicola Poloni, Ivano Caselli, et al.
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 35-42
Open Access | Times Cited: 35
A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project
Srividya N. Iyer, Jai Shah, Patricia Boksa, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Development and Validation of a Novel At-home Smell Assessment
Shruti Gupta, Dorina Kallogjeri, Nyssa Fox Farrell, et al.
JAMA Otolaryngology–Head & Neck Surgery (2022) Vol. 148, Iss. 3, pp. 252-252
Open Access | Times Cited: 18
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, Vicent Balanzá‐Martínez, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100962-100962
Open Access
The Effects of Echinacea (EP107TM) on Anxiety: A Comparison of Anxiety Measures in a Randomized, Double Blind, Placebo-Controlled Study
József Haller, Gábor Faludi, Gábor G. Kovács, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 264-264
Open Access
An Approach to Providing Timely Mental Health Services to Diverse Youth Populations
Srividya N. Iyer, Patricia Boksa, Ridha Joober, et al.
JAMA Psychiatry (2025)
Closed Access
Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: A long-term retrospective review of clinical use
Steven Best, Dan G. Pavel, Natalie Haustrup
Heliyon (2019) Vol. 5, Iss. 8, pp. e02187-e02187
Open Access | Times Cited: 27
Artificial Intelligence and Machine Learning Techniques for Suicide Prediction: Integrating Dietary Patterns and Environmental Contaminants
Mayyas Al‐Remawi, Ahmed S.A. Ali Agha, Faisal Al‐Akayleh, et al.
Heliyon (2024) Vol. 10, Iss. 24, pp. e40925-e40925
Open Access | Times Cited: 3
Increased inflammasome activity in markedly ill psychiatric patients: An explorative study
Ulrika Hylén, Daniel Eklund, Mats B. Humble, et al.
Journal of Neuroimmunology (2019) Vol. 339, pp. 577119-577119
Open Access | Times Cited: 25
Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension
Brenda Leung, Priya Srikanth, Lisa M. Robinette, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 5, pp. 1355-1367
Closed Access | Times Cited: 7
<p>Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders</p>
Honghua Li, Zhida Xu, Bing Wang, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2443-2450
Open Access | Times Cited: 21
Development of an adapted Clinical Global Impression scale for use in Angelman syndrome
Alexander Kolevzon, Pamela Ventola, Christopher J. Keary, et al.
Journal of Neurodevelopmental Disorders (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Natural trajectory of recovery of COVID-19 associated olfactory loss
Amish M. Khan, Jake J. Lee, Thue Rammaha, et al.
American Journal of Otolaryngology (2022) Vol. 43, Iss. 5, pp. 103572-103572
Open Access | Times Cited: 11
Trends in (not) using scales in major depression: A categorization and clinical orientation
Koen Demyttenaere, Liesbeth Jaspers
European Psychiatry (2020) Vol. 63, Iss. 1
Open Access | Times Cited: 16
Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Ashna Mahadev, Firas Hentati, Brevin Miller, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 12, pp. 1111-1111
Open Access | Times Cited: 5
Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium
B. Gillain, G. Degraeve, Thomas D. Dreesen, et al.
PharmacoEconomics - Open (2021) Vol. 6, Iss. 2, pp. 293-302
Open Access | Times Cited: 12
Enhancing sleep quality for nursing home residents with dementia: a pragmatic randomized controlled trial of an evidence-based frontline huddling program
A. Lynn Snow, Julia Loup, Robert O. Morgan, et al.
BMC Geriatrics (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Oxcarbazepine for the treatment of bipolar and depressive disorders in the outpatient setting: A retrospective chart review
Brandon Brown, Brian Tong, Luke Pro, et al.
Psychiatry Research Communications (2024) Vol. 4, Iss. 2, pp. 100171-100171
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top